Emerald, the International PhD Programme for Medical Doctors, is a pioneering European-wide training programme for physician-scientists. It has received funding from the European Union's Horizon 2020 programme under the Marie Skłodowska-Curie Actions (MSCA). The MSCA aims to equip researchers with the necessary skills and international experience for a successful career, either in the public or the private sector.
The Emerald project aims to push forward personalised medicine by fusing fundamental discoveries and frontier technologies with translational research and medicine. The project's vision is to facilitate a healthcare and medical system with highly skilled professionals who can bridge research and patients’ needs, understand different professional cultures, and can work at the interface of diverse disciplines.
In order to do so, Emerald will provide 24 medical doctors with state-of-the-art biomedicine training and help bridge the gap between laboratory research and clinical practice. It will also offer them the unique opportunity to move to a different country to conduct a cutting-edge PhD research project, participate in tailored summer schools, benefit from peer-mentoring and explore and establish new collaborations.
Emerald is a EU-LIFE-based consortium led by seven members of our alliance: CRG, Institut Curie, BRIC, IGC, MDC, NKI, and VIB. EU-LIFE was instrumental in the consortium creation and the project design. In addition, and alongside these seven host institutions, EU-LIFE is one of 37 partner organisations from 10 European countries, including universities, hospitals, patient associations, pharmaceutical companies and publishers.
Facts and Figures